Icon

HYCAMTIN (nda020671)- (EQ 4MG BASE/VIAL)

TOPOTECAN HYDROCHLORIDE SANDOZ
EQ 4MG BASE/VIAL
No No
2015-Apr-07 Expired
None None
None No
HYCAMTIN capsules is a topoisomerase inhibitor indicated for treatment of patients with relapsed small cell lung cancer (SCLC).
7 0 4
Total Other Developers None
Drugs with Suitability No
EQ 4MG BASE/VIAL ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 3
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ******* ****** ******-****** *** *********** *** ********* ****. **. **, ******** *, *********, ******, ******* (***) ***
****** ********* **** *** ********* **** ***, *** *********** **** ****** ****, ***** ******, *** **** (**) *****, ****** ****** (***) ***
****** ********* **** *** ********** ******, ***. *** *********** **.*, ***-** *** ****, ****-***, ******, *****, ****** (***) ***
****** ** ****** **** *** ***** ******* *********** **** ** ****, *-*** ** *-***, *-*** ** *-***, **** ** *-***/*/*/*, *-****, *-***, *-***, *-***, ***** ********** ****, ********, *** ******, ***** (***) ***
****** ****** ******** ***** *************** ******* *********** **** **. ***/***-****** / **** **.***/****-*********** , *******-***** ******* , ****** -******, ******, *********, ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.